Articles
Volume 7 Supplement 2
The Third International Symposium on the Molecular Biology of Breast Cancer
- Meeting abstracts
- from The Third International Symposium on the Molecular Biology of Breast Cancer
- Molde, Norway
- 22-26 June 2005
- Affymetrix, Agilent Technologies, Applied Biosystems, AstraZeneca, Novartis Oncology, Pfizer, Roche Diagnostics (Main Sponsors).
|
Oral Presentation
N Davidson Breast Cancer Research 2005, 7(Suppl 2):S.01 (17 June 2005) |
|
Oral Presentation
Stromal and epithelial TGF-β signaling in mammary tumorigenesis HL Moses, N Cheng, A Chytil, AE Gorska, M Aakre, E Forrester, EG Neilson, NA Bhowmick Breast Cancer Research 2005, 7(Suppl 2):S.02-S44 (17 June 2005) |
|
Oral Presentation
Genomic analysis of human breast cancer in families and populations M-C King Breast Cancer Research 2005, 7(Suppl 2):S.03 (17 June 2005) |
|
Oral Presentation
Breast Cancer Research 2005, 7(Suppl 2):S.04 (17 June 2005) |
|
Oral Presentation
ATM mutations associated with breast cancer RA Gatti, P Concannon Breast Cancer Research 2005, 7(Suppl 2):S.05 (17 June 2005) |
|
Oral Presentation
DNA damage response pathways in cancer causation and treatment MB Kastan, R Kitagawa, CJ Bakkenist Breast Cancer Research 2005, 7(Suppl 2):S.06 (17 June 2005) |
|
Oral Presentation
SNPS in putative regulatory loci controlling gene expression in cancer VN Kristensen Breast Cancer Research 2005, 7(Suppl 2):S.07 (17 June 2005) |
|
Oral Presentation
Potential mechanisms whereby estrogens induce breast cancer in women RJ Santen, W Yue, J-P Wang Breast Cancer Research 2005, 7(Suppl 2):S.08 (17 June 2005) |
|
Oral Presentation
The future of breast cancer prevention A Howell, A Sims, M Harvie, KR Ong, G Evans, R Clarke Breast Cancer Research 2005, 7(Suppl 2):S.09 (17 June 2005) |
|
Oral Presentation
Targeting estrogen to kill ER-positive and ER-negative breast cancer VC Jordan Breast Cancer Research 2005, 7(Suppl 2):S.10 (17 June 2005) |
|
Oral Presentation
ERβ in normal and malignant breast J-Å Gustafsson, G Cheng, M Warner Breast Cancer Research 2005, 7(Suppl 2):S.11 (17 June 2005) |
|
Oral Presentation
Molecular approaches to understanding pregnancy-induced protection against breast cancer CM Blakely, SE Moody, A Stoddard, E Tombler, C Liu, LA Chodosh Breast Cancer Research 2005, 7(Suppl 2):S.12 (17 June 2005) |
|
Oral Presentation
Predicting response/resistance to endocrine therapy for breast cancer WR Miller, TJ Anderson, D Evans, A Krause, JM Dixon Breast Cancer Research 2005, 7(Suppl 2):S.13 (17 June 2005) |
|
Oral Presentation
Genetic and epigenetic changes in early carcinogenesis TD Tlsty Breast Cancer Research 2005, 7(Suppl 2):S.14 (17 June 2005) |
|
Oral Presentation
MJ Bissell, C Myers, G Lee, E Lee, A Rizki, S Mian, J Gray, D Radisky Breast Cancer Research 2005, 7(Suppl 2):S.15 (17 June 2005) |
|
Oral Presentation
Genomic and transcriptional events associated with poor clinical responses to conventional therapies K Chin, S Devries, J Fridlyand, P Spellman, W-L Kuo, A Lapuk, R Neve, T Tokuyasu, C Kingsley, S Dairkee, K Chew, A Jain, BM Ljung, L Esserman, F Waldman, JW Gray Breast Cancer Research 2005, 7(Suppl 2):S.16 (17 June 2005) |
|
Oral Presentation
The role of the tumor microenvironment in breast cancer progression H Min, J Yao, M Allinen, L Cai, K Polyak Breast Cancer Research 2005, 7(Suppl 2):S.17 (17 June 2005) |
|
Oral Presentation
Biological features and xenograft models of a very early human premalignant breast lesion S Lee, Y Wu, SK Mohsin, D Medina, DC Allred Breast Cancer Research 2005, 7(Suppl 2):S.18 (17 June 2005) |
|
Oral Presentation
Regulation of epithelial cell polarity during carcinogenesis SK Muthuswamy Breast Cancer Research 2005, 7(Suppl 2):S.19 (17 June 2005) |
|
Oral Presentation
Expression profiling of peripheral blood cells for early detection A-L Børresen-Dale, P Sharma Breast Cancer Research 2005, 7(Suppl 2):S.20 (17 June 2005) |
